Investors Similar to Thomas Clozel
Discover 19 alternative investors with similar investment focus, angel structure, and track record.
Target Investor
Thomas Clozel
Thomas Clozel is a French oncologist, entrepreneur, and angel investor — co-founder and CEO of Owkin, a scientific AI company that leverages machine learning to enhance medical research, valued at over $1 billion following Sanofi's investment in 2021. He is the son of Jean-Paul and Martine Clozel, founders of Swiss biotech Actelion. His angel investments span AI, biotech, and climate innovation.
Similar Investors
Showing 19 results
About This Comparison
This alternatives page shows investors with similar characteristics to Thomas Clozel, including similar angel structure, comparable investment focus, and track record. Use this page to discover alternative investors for your funding strategy, investor mapping, or competitive analysis.
Investors are ranked by total score, which reflects portfolio size, investment activity, and market presence on StartupHub.ai. Learn more about each investor by clicking their profile to see portfolio companies, investment rounds, and detailed information.
StartupHub.ai provides free access to investor profiles, funding data, and startup intelligence. No paywall, no enterprise subscription required.